Analysed MICROBOT MEDICAL INC (MBOT:NASDAQ) News Sources
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
05-05-2026
yahoo.com
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
14-05-2026
yahoo.com
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
15-05-2026
yahoo.com
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans
16-05-2026
yahoo.com
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
19-05-2026
yahoo.com
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
26-05-2026
yahoo.com
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02-06-2026
yahoo.com
What is the current price of MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The current price of MICROBOT MEDICAL INC (MBOT:NASDAQ) is $1.78.
MICROBOT MEDICAL INC (MBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of MICROBOT MEDICAL INC (MBOT:NASDAQ) since the previous trading day is $-0.04.
MICROBOT MEDICAL INC (MBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of MICROBOT MEDICAL INC (MBOT:NASDAQ) since the previous trading day is -2.1978%.
What is the most recent average sentiment score for MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The most recent average sentiment score for MICROBOT MEDICAL INC (MBOT:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The most recent sentiment for MICROBOT MEDICAL INC (MBOT:NASDAQ) is .
SEC-8K** Filing Available For MICROBOT MEDICAL INC (MBOT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.